Diabetes lures pharma to the Gulf

Share this article:

Diabetes is a growing problem and pharmaceutical opportunity in Saudi Arabia. The Wall Street Journal outlines the health crisis that is increasingly visible during mall walks that double as a respite from the heat and a time to mingle over fast food.

The Journal also notes that governments in the Gulf have offered a mix of financial incentives to coax businesses to take manufacturing local, and that companies like Merck KGaA have partnered with local producers as a way of getting a foothold in the market.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Pfizer seeks wider Xeljanz indication

The company expects to file an sNDA for plaque psoriasis next year.

Recalls dent Stryker Q1 earnings

Sales rose 5% compared to the same period last year.